logo
welcome
Reuters

Reuters

EU drugs regulator reviews anti hair-loss drugs over suicidal thoughts concerns

Reuters
Summary
Nutrition label

79% Informative

European drugs regulator reviewing anti hair-loss drugs for potential risk of suicidal thoughts and behaviour associated with them.

Oral anti-baldness drugs, which contain finasteride and dutasteride, have a known risk of psychiatric side effects, including depression.

These drugs are sold under the brand name Propecia and Avodart by Organon , a Merck spin-off, and British drugmaker GSK .

VR Score

88

Informative language

93

Neutral language

73

Article tone

formal

Language

English

Language complexity

58

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links